nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ABCG2—Topotecan—cervical cancer	0.438	0.634	CbGbCtD
Mycophenolate mofetil—ABCB1—Topotecan—cervical cancer	0.158	0.229	CbGbCtD
Mycophenolate mofetil—CYP3A4—Topotecan—cervical cancer	0.0946	0.137	CbGbCtD
Mycophenolate mofetil—Lung neoplasm malignant—Topotecan—cervical cancer	0.0126	0.104	CcSEcCtD
Mycophenolate mofetil—UGT1A7—renal system—cervical cancer	0.0108	0.0571	CbGeAlD
Mycophenolate mofetil—UGT1A10—renal system—cervical cancer	0.00902	0.0478	CbGeAlD
Mycophenolate mofetil—UGT1A8—renal system—cervical cancer	0.00713	0.0378	CbGeAlD
Mycophenolate mofetil—UGT1A9—renal system—cervical cancer	0.00453	0.024	CbGeAlD
Mycophenolate mofetil—IMPDH2—uterine cervix—cervical cancer	0.00429	0.0227	CbGeAlD
Mycophenolate mofetil—IMPDH1—uterine cervix—cervical cancer	0.00427	0.0226	CbGeAlD
Mycophenolate mofetil—Pelvic pain—Topotecan—cervical cancer	0.00416	0.0344	CcSEcCtD
Mycophenolate mofetil—IMPDH2—decidua—cervical cancer	0.00409	0.0217	CbGeAlD
Mycophenolate mofetil—IMPDH1—decidua—cervical cancer	0.00406	0.0215	CbGeAlD
Mycophenolate mofetil—IMPDH2—renal system—cervical cancer	0.00402	0.0213	CbGeAlD
Mycophenolate mofetil—IMPDH1—renal system—cervical cancer	0.00399	0.0211	CbGeAlD
Mycophenolate mofetil—CES2—uterine cervix—cervical cancer	0.0039	0.0207	CbGeAlD
Mycophenolate mofetil—IMPDH2—endometrium—cervical cancer	0.00388	0.0206	CbGeAlD
Mycophenolate mofetil—IMPDH1—endometrium—cervical cancer	0.00386	0.0204	CbGeAlD
Mycophenolate mofetil—IMPDH2—mammalian vulva—cervical cancer	0.00376	0.0199	CbGeAlD
Mycophenolate mofetil—IMPDH1—mammalian vulva—cervical cancer	0.00373	0.0198	CbGeAlD
Mycophenolate mofetil—CES2—decidua—cervical cancer	0.00372	0.0197	CbGeAlD
Mycophenolate mofetil—CES2—renal system—cervical cancer	0.00365	0.0193	CbGeAlD
Mycophenolate mofetil—UGT2B7—renal system—cervical cancer	0.00365	0.0193	CbGeAlD
Mycophenolate mofetil—Interstitial lung disease—Topotecan—cervical cancer	0.00358	0.0296	CcSEcCtD
Mycophenolate mofetil—Lung disorder—Topotecan—cervical cancer	0.00358	0.0296	CcSEcCtD
Mycophenolate mofetil—IMPDH2—uterus—cervical cancer	0.00358	0.0189	CbGeAlD
Mycophenolate mofetil—IMPDH1—uterus—cervical cancer	0.00355	0.0188	CbGeAlD
Mycophenolate mofetil—CES2—endometrium—cervical cancer	0.00353	0.0187	CbGeAlD
Mycophenolate mofetil—CES2—mammalian vulva—cervical cancer	0.00341	0.0181	CbGeAlD
Mycophenolate mofetil—Pleural effusion—Topotecan—cervical cancer	0.00331	0.0273	CcSEcCtD
Mycophenolate mofetil—CES2—uterus—cervical cancer	0.00325	0.0172	CbGeAlD
Mycophenolate mofetil—SLCO1B3—vagina—cervical cancer	0.00323	0.0171	CbGeAlD
Mycophenolate mofetil—IMPDH2—female reproductive system—cervical cancer	0.00322	0.017	CbGeAlD
Mycophenolate mofetil—IMPDH1—female reproductive system—cervical cancer	0.0032	0.0169	CbGeAlD
Mycophenolate mofetil—UGT1A1—renal system—cervical cancer	0.0031	0.0164	CbGeAlD
Mycophenolate mofetil—IMPDH2—female gonad—cervical cancer	0.00293	0.0155	CbGeAlD
Mycophenolate mofetil—CES2—female reproductive system—cervical cancer	0.00292	0.0155	CbGeAlD
Mycophenolate mofetil—UGT2B7—female reproductive system—cervical cancer	0.00292	0.0155	CbGeAlD
Mycophenolate mofetil—IMPDH2—vagina—cervical cancer	0.00291	0.0154	CbGeAlD
Mycophenolate mofetil—IMPDH1—female gonad—cervical cancer	0.00291	0.0154	CbGeAlD
Mycophenolate mofetil—IMPDH1—vagina—cervical cancer	0.00289	0.0153	CbGeAlD
Mycophenolate mofetil—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00279	0.023	CcSEcCtD
Mycophenolate mofetil—CES2—female gonad—cervical cancer	0.00266	0.0141	CbGeAlD
Mycophenolate mofetil—Bone pain—Topotecan—cervical cancer	0.00265	0.0218	CcSEcCtD
Mycophenolate mofetil—CES2—vagina—cervical cancer	0.00264	0.014	CbGeAlD
Mycophenolate mofetil—SLCO1B1—renal system—cervical cancer	0.00258	0.0137	CbGeAlD
Mycophenolate mofetil—Respiratory failure—Topotecan—cervical cancer	0.00258	0.0213	CcSEcCtD
Mycophenolate mofetil—Pulmonary embolism—Topotecan—cervical cancer	0.00253	0.0209	CcSEcCtD
Mycophenolate mofetil—Colitis—Topotecan—cervical cancer	0.00243	0.0201	CcSEcCtD
Mycophenolate mofetil—CES1—female reproductive system—cervical cancer	0.00241	0.0127	CbGeAlD
Mycophenolate mofetil—Neuropathy—Topotecan—cervical cancer	0.00238	0.0196	CcSEcCtD
Mycophenolate mofetil—Rash maculo-papular—Topotecan—cervical cancer	0.0023	0.019	CcSEcCtD
Mycophenolate mofetil—Neoplasm—Topotecan—cervical cancer	0.00229	0.0189	CcSEcCtD
Mycophenolate mofetil—Sepsis—Topotecan—cervical cancer	0.0022	0.0182	CcSEcCtD
Mycophenolate mofetil—CES1—female gonad—cervical cancer	0.00219	0.0116	CbGeAlD
Mycophenolate mofetil—Ear pain—Topotecan—cervical cancer	0.00216	0.0178	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—female reproductive system—cervical cancer	0.00207	0.011	CbGeAlD
Mycophenolate mofetil—ABCC2—renal system—cervical cancer	0.00196	0.0104	CbGeAlD
Mycophenolate mofetil—Dermatitis bullous—Topotecan—cervical cancer	0.00192	0.0159	CcSEcCtD
Mycophenolate mofetil—IMPDH2—lymph node—cervical cancer	0.00188	0.00996	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—cervical cancer	0.00187	0.0099	CbGeAlD
Mycophenolate mofetil—Cardiac arrest—Topotecan—cervical cancer	0.00175	0.0144	CcSEcCtD
Mycophenolate mofetil—CES2—lymph node—cervical cancer	0.00171	0.00906	CbGeAlD
Mycophenolate mofetil—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00166	0.0137	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00162	0.0134	CcSEcCtD
Mycophenolate mofetil—ABCC2—female reproductive system—cervical cancer	0.00157	0.0083	CbGeAlD
Mycophenolate mofetil—ABCG2—uterine cervix—cervical cancer	0.00153	0.00808	CbGeAlD
Mycophenolate mofetil—Pancytopenia—Topotecan—cervical cancer	0.00151	0.0125	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Topotecan—cervical cancer	0.00149	0.0123	CcSEcCtD
Mycophenolate mofetil—CYP2C8—renal system—cervical cancer	0.00147	0.00778	CbGeAlD
Mycophenolate mofetil—ABCG2—decidua—cervical cancer	0.00145	0.0077	CbGeAlD
Mycophenolate mofetil—Weight increased—Topotecan—cervical cancer	0.00145	0.0119	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Topotecan—cervical cancer	0.00143	0.0118	CcSEcCtD
Mycophenolate mofetil—CYP2C8—endometrium—cervical cancer	0.00142	0.00752	CbGeAlD
Mycophenolate mofetil—Infestation—Topotecan—cervical cancer	0.00142	0.0117	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Topotecan—cervical cancer	0.00142	0.0117	CcSEcCtD
Mycophenolate mofetil—CYP3A5—uterine cervix—cervical cancer	0.00142	0.0075	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—cervical cancer	0.00141	0.00746	CbGeAlD
Mycophenolate mofetil—Neuropathy peripheral—Topotecan—cervical cancer	0.00139	0.0115	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Topotecan—cervical cancer	0.00138	0.0114	CcSEcCtD
Mycophenolate mofetil—ABCG2—endometrium—cervical cancer	0.00138	0.00731	CbGeAlD
Mycophenolate mofetil—Sweating—Topotecan—cervical cancer	0.00136	0.0112	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Topotecan—cervical cancer	0.00134	0.0111	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Topotecan—cervical cancer	0.00134	0.011	CcSEcCtD
Mycophenolate mofetil—ABCG2—mammalian vulva—cervical cancer	0.00134	0.00707	CbGeAlD
Mycophenolate mofetil—CYP3A5—renal system—cervical cancer	0.00133	0.00702	CbGeAlD
Mycophenolate mofetil—Haemoglobin—Topotecan—cervical cancer	0.00128	0.0106	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Topotecan—cervical cancer	0.00128	0.0105	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Topotecan—cervical cancer	0.00127	0.0105	CcSEcCtD
Mycophenolate mofetil—ABCG2—uterus—cervical cancer	0.00127	0.00674	CbGeAlD
Mycophenolate mofetil—Hypoaesthesia—Topotecan—cervical cancer	0.00127	0.0105	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Topotecan—cervical cancer	0.00126	0.0104	CcSEcCtD
Mycophenolate mofetil—CYP2C8—female reproductive system—cervical cancer	0.00118	0.00623	CbGeAlD
Mycophenolate mofetil—Angiopathy—Topotecan—cervical cancer	0.00115	0.00954	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Topotecan—cervical cancer	0.00115	0.00947	CcSEcCtD
Mycophenolate mofetil—Chills—Topotecan—cervical cancer	0.00114	0.00943	CcSEcCtD
Mycophenolate mofetil—Alopecia—Topotecan—cervical cancer	0.00112	0.00929	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Topotecan—cervical cancer	0.00111	0.00915	CcSEcCtD
Mycophenolate mofetil—Back pain—Topotecan—cervical cancer	0.00107	0.00885	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Topotecan—cervical cancer	0.00106	0.0088	CcSEcCtD
Mycophenolate mofetil—CYP2C8—vagina—cervical cancer	0.00106	0.00563	CbGeAlD
Mycophenolate mofetil—ABCG2—female gonad—cervical cancer	0.00104	0.00551	CbGeAlD
Mycophenolate mofetil—ABCG2—vagina—cervical cancer	0.00103	0.00548	CbGeAlD
Mycophenolate mofetil—Ill-defined disorder—Topotecan—cervical cancer	0.00103	0.00849	CcSEcCtD
Mycophenolate mofetil—Anaemia—Topotecan—cervical cancer	0.00102	0.00846	CcSEcCtD
Mycophenolate mofetil—Angioedema—Topotecan—cervical cancer	0.00101	0.00836	CcSEcCtD
Mycophenolate mofetil—Malaise—Topotecan—cervical cancer	0.000999	0.00825	CcSEcCtD
Mycophenolate mofetil—CYP3A4—renal system—cervical cancer	0.000994	0.00527	CbGeAlD
Mycophenolate mofetil—Leukopenia—Topotecan—cervical cancer	0.000991	0.00819	CcSEcCtD
Mycophenolate mofetil—ALB—lymph node—cervical cancer	0.000979	0.00518	CbGeAlD
Mycophenolate mofetil—Cough—Topotecan—cervical cancer	0.000967	0.00798	CcSEcCtD
Mycophenolate mofetil—CYP3A5—female gonad—cervical cancer	0.000966	0.00511	CbGeAlD
Mycophenolate mofetil—CYP3A5—vagina—cervical cancer	0.00096	0.00508	CbGeAlD
Mycophenolate mofetil—Chest pain—Topotecan—cervical cancer	0.000943	0.00779	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Topotecan—cervical cancer	0.000943	0.00779	CcSEcCtD
Mycophenolate mofetil—Myalgia—Topotecan—cervical cancer	0.000943	0.00779	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000936	0.00774	CcSEcCtD
Mycophenolate mofetil—Discomfort—Topotecan—cervical cancer	0.000932	0.0077	CcSEcCtD
Mycophenolate mofetil—ABCC2—lymph node—cervical cancer	0.000917	0.00486	CbGeAlD
Mycophenolate mofetil—Anaphylactic shock—Topotecan—cervical cancer	0.000904	0.00747	CcSEcCtD
Mycophenolate mofetil—Infection—Topotecan—cervical cancer	0.000898	0.00742	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Topotecan—cervical cancer	0.000887	0.00732	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Topotecan—cervical cancer	0.000885	0.00731	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Topotecan—cervical cancer	0.000878	0.00725	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Topotecan—cervical cancer	0.000874	0.00722	CcSEcCtD
Mycophenolate mofetil—Anorexia—Topotecan—cervical cancer	0.000862	0.00712	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000824	0.0068	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Topotecan—cervical cancer	0.000812	0.0067	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Topotecan—cervical cancer	0.000806	0.00666	CcSEcCtD
Mycophenolate mofetil—CYP3A4—female reproductive system—cervical cancer	0.000796	0.00422	CbGeAlD
Mycophenolate mofetil—Dyspepsia—Topotecan—cervical cancer	0.000796	0.00657	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Topotecan—cervical cancer	0.000786	0.00649	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Topotecan—cervical cancer	0.00078	0.00645	CcSEcCtD
Mycophenolate mofetil—Pain—Topotecan—cervical cancer	0.000773	0.00639	CcSEcCtD
Mycophenolate mofetil—Constipation—Topotecan—cervical cancer	0.000773	0.00639	CcSEcCtD
Mycophenolate mofetil—ABCB1—epithelium—cervical cancer	0.000759	0.00402	CbGeAlD
Mycophenolate mofetil—ABCB1—uterine cervix—cervical cancer	0.000752	0.00399	CbGeAlD
Mycophenolate mofetil—Feeling abnormal—Topotecan—cervical cancer	0.000745	0.00615	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Topotecan—cervical cancer	0.000739	0.00611	CcSEcCtD
Mycophenolate mofetil—Urticaria—Topotecan—cervical cancer	0.000718	0.00593	CcSEcCtD
Mycophenolate mofetil—ABCB1—decidua—cervical cancer	0.000717	0.0038	CbGeAlD
Mycophenolate mofetil—Body temperature increased—Topotecan—cervical cancer	0.000715	0.0059	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Topotecan—cervical cancer	0.000715	0.0059	CcSEcCtD
Mycophenolate mofetil—ABCB1—renal system—cervical cancer	0.000704	0.00373	CbGeAlD
Mycophenolate mofetil—ABCB1—endometrium—cervical cancer	0.000681	0.0036	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—cervical cancer	0.000669	0.00354	CbGeAlD
Mycophenolate mofetil—Hypersensitivity—Topotecan—cervical cancer	0.000666	0.0055	CcSEcCtD
Mycophenolate mofetil—ABCB1—mammalian vulva—cervical cancer	0.000658	0.00349	CbGeAlD
Mycophenolate mofetil—Asthenia—Topotecan—cervical cancer	0.000649	0.00536	CcSEcCtD
Mycophenolate mofetil—Pruritus—Topotecan—cervical cancer	0.00064	0.00528	CcSEcCtD
Mycophenolate mofetil—ABCB1—uterus—cervical cancer	0.000627	0.00332	CbGeAlD
Mycophenolate mofetil—Diarrhoea—Topotecan—cervical cancer	0.000619	0.00511	CcSEcCtD
Mycophenolate mofetil—Dizziness—Topotecan—cervical cancer	0.000598	0.00494	CcSEcCtD
Mycophenolate mofetil—Vomiting—Topotecan—cervical cancer	0.000575	0.00475	CcSEcCtD
Mycophenolate mofetil—Rash—Topotecan—cervical cancer	0.00057	0.00471	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Topotecan—cervical cancer	0.000569	0.0047	CcSEcCtD
Mycophenolate mofetil—Headache—Topotecan—cervical cancer	0.000566	0.00468	CcSEcCtD
Mycophenolate mofetil—ABCB1—female reproductive system—cervical cancer	0.000564	0.00299	CbGeAlD
Mycophenolate mofetil—Nausea—Topotecan—cervical cancer	0.000537	0.00444	CcSEcCtD
Mycophenolate mofetil—ABCB1—female gonad—cervical cancer	0.000513	0.00272	CbGeAlD
Mycophenolate mofetil—ABCB1—vagina—cervical cancer	0.00051	0.0027	CbGeAlD
Mycophenolate mofetil—ABCB1—lymph node—cervical cancer	0.00033	0.00175	CbGeAlD
